Literature DB >> 16283620

Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.

Juliet D French1, Jasmyn Dunn, Chanel E Smart, Nathan Manning, Melissa A Brown.   

Abstract

BRCA1 is a tumor suppressor that functions in controlling cell growth and maintaining genomic stability. BRCA1 has also been implicated in telomere maintenance through its ability to regulate the transcription of hTERT, the catalytic subunit of telomerase, resulting in telomere shortening, and to colocalize with the telomere-binding protein TRF1. The high incidence of nonreciprocal translocations in tumors arising from BRCA1 mutation carriers and Brca1-null mice also raises the possibility that BRCA1 plays a role in telomere protection. To date, however, the consequences for telomere status of disrupting BRCA1 have not been reported. To examine the role of BRCA1 in telomere regulation, we have expressed a dominant-negative mutant of BRCA1 (trBRCA1), known to disrupt multiple functions of BRCA1, in telomerase-positive mammary epithelial cells (SVCT) and telomerase-negative ALT cells (GM847). In SVCT cells, expression of trBRCA1 resulted in an increased incidence of anaphase bridges and in an increase in telomere length, but no change in telomerase activity. In GM847 cells, trBRCA1 also increased anaphase bridge formation but did not induce any change in telomere length. BRCA1 colocalized with TRF2 in telomerase-positive cells and with a small subset of ALT-associated PML bodies (APBs) in ALT cells. Together, these results raise the possibility that BRCA1 could play a role in telomere protection and suggest a potential mechanism for one of the phenotypes of BRCA1-deficient cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16283620     DOI: 10.1002/gcc.20290

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.

Authors:  Rahul D Ballal; Tapas Saha; Saijun Fan; Bassam R Haddad; Eliot M Rosen
Journal:  J Biol Chem       Date:  2009-09-21       Impact factor: 5.157

Review 2.  BRCA1 and BRCA2 mutations and female fertility.

Authors:  Ken R Smith; Heidi A Hanson; Michael S Hollingshaus
Journal:  Curr Opin Obstet Gynecol       Date:  2013-06       Impact factor: 1.927

3.  Effects of BRCA1 and BRCA2 mutations on female fertility.

Authors:  Ken R Smith; Heidi A Hanson; Geraldine P Mineau; Saundra S Buys
Journal:  Proc Biol Sci       Date:  2011-10-12       Impact factor: 5.349

4.  Human ovarian tissue cortex surrounding benign and malignant lesions.

Authors:  Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Candace Tingen; Cristina Thomas; Jessina Thomas; M Patrick Lowe; Julian C Schink; Teresa K Woodruff
Journal:  Reprod Sci       Date:  2013-10-04       Impact factor: 3.060

5.  Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis.

Authors:  Christina N Cordeiro Mitchell; Bailey McGuinness; Eliana Fine; William G Kearns; Mindy S Christianson; James Segars; Lisa M Pastore
Journal:  J Assist Reprod Genet       Date:  2020-03-24       Impact factor: 3.412

6.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

7.  APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage.

Authors:  Lorenzo Lafranchi; Harmen R de Boer; Elisabeth G E de Vries; Shao-En Ong; Alessandro A Sartori; Marcel A T M van Vugt
Journal:  EMBO J       Date:  2014-10-27       Impact factor: 11.598

8.  Nondisjunction of a single chromosome leads to breakage and activation of DNA damage checkpoint in G2.

Authors:  Oliver Quevedo; Jonay García-Luis; Emiliano Matos-Perdomo; Luis Aragón; Félix Machín
Journal:  PLoS Genet       Date:  2012-02-16       Impact factor: 5.917

9.  Telomerase-independent paths to immortality in predictable cancer subtypes.

Authors:  Stephen T Durant
Journal:  J Cancer       Date:  2012-01-31       Impact factor: 4.207

10.  Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.

Authors:  Karen A Pooley; Lesley McGuffog; Daniel Barrowdale; Debra Frost; Steve D Ellis; Elena Fineberg; Radka Platte; Louise Izatt; Julian Adlard; Julian Bardwell; Carole Brewer; Trevor Cole; Jackie Cook; Rosemarie Davidson; Alan Donaldson; Huw Dorkins; Fiona Douglas; Jacqueline Eason; Catherine Houghton; M John Kennedy; Emma McCann; Zosia Miedzybrodzka; Alex Murray; Mary E Porteous; Mark T Rogers; Lucy E Side; Marc Tischkowitz; Lisa Walker; Shirley Hodgson; Diana M Eccles; Patrick J Morrison; D Gareth Evans; Rosalind A Eeles; Antonis C Antoniou; Douglas F Easton; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-18       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.